Cited 0 times in
Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김기준 | - |
dc.contributor.author | 김명화 | - |
dc.contributor.author | 유영철 | - |
dc.contributor.author | 이정림 | - |
dc.contributor.author | 전지혜 | - |
dc.contributor.author | 오주은 | - |
dc.date.accessioned | 2021-12-28T17:37:21Z | - |
dc.date.available | 2021-12-28T17:37:21Z | - |
dc.date.issued | 2021-11 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/187189 | - |
dc.description.abstract | In our previous research showed that tramadol having potential anti-tumor effect was associated with enhancement of oncological prognosis in patients with breast cancer surgery. As these effects have not been confirmed by clinical dose-regulated animal or prospective human studies, we investigated the anti-tumor effect of tramadol in vivo. Female nude mice orthotopically inoculated with luciferase-expressing MCF-7 cells, were randomly divided into the control (saline), tramadol group 1 (1.5 mg kg-1 day-1), tramadol group 2 (3 mg kg-1 day-1), and morphine (0.5 mg kg-1 day-1) (n = 5/group). Bioluminescence signals after D-luciferin injection, tumor size, and tumor weight were compared among groups after 4 weeks. Estrogen receptor (ER), progesterone receptor (PR), and transient receptor potential vanilloid (TRPV)-1 expression, natural killer (NK) cell activity, and serum interleukin (IL)-1β, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and interleukin (IL)-6 were then examined. Tumour growth was attenuated in tramadol-treated groups (P < 0.05). NK cell activity was significantly decreased only in the morphine treated group not in sham, control, and tramadol groups. The expression levels of ERα, PRα and β, and TRPV1 were decreased in tramadol group 2 compared with those in the morphine group, but not compared to the control group. Serum levels of IL-6 and TNFα were reduced in both tramadol-treated group 1 and 2 compared to the control group. Overall, clinical dose of tramadol has anti-tumour effects on MCF-7 cell-derived breast cancer in a xenograft mouse model. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | Nature Publishing Group | - |
dc.relation.isPartOf | SCIENTIFIC REPORTS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) | - |
dc.contributor.googleauthor | Myoung Hwa Kim | - |
dc.contributor.googleauthor | Jeong-Rim Lee | - |
dc.contributor.googleauthor | Ki-Joon Kim | - |
dc.contributor.googleauthor | Ji Hae Jun | - |
dc.contributor.googleauthor | Hye Jeong Hwang | - |
dc.contributor.googleauthor | Wootaek Lee | - |
dc.contributor.googleauthor | Seung Hyun Nam | - |
dc.contributor.googleauthor | Ju Eun Oh | - |
dc.contributor.googleauthor | Young Chul Yoo | - |
dc.identifier.doi | 10.1038/s41598-021-01701-9 | - |
dc.contributor.localId | A00340 | - |
dc.contributor.localId | A00429 | - |
dc.contributor.localId | A02484 | - |
dc.contributor.localId | A03098 | - |
dc.relation.journalcode | J02646 | - |
dc.identifier.eissn | 2045-2322 | - |
dc.identifier.pmid | 34764420 | - |
dc.contributor.alternativeName | Kim, Ki Jun | - |
dc.contributor.affiliatedAuthor | 김기준 | - |
dc.contributor.affiliatedAuthor | 김명화 | - |
dc.contributor.affiliatedAuthor | 유영철 | - |
dc.contributor.affiliatedAuthor | 이정림 | - |
dc.citation.volume | 11 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 22113 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, Vol.11(1) : 22113, 2021-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.